Phillip Lynch
Director/Board Member at RACE ONCOLOGY LIMITED
Net worth: 367 212 $ as of 29/04/2024
Network origin in Phillip Lynch first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 18 | |
Consumer Healthcare Products Australia Ltd.
 Consumer Healthcare Products Australia Ltd. Miscellaneous Commercial ServicesCommercial Services Consumer Healthcare Products Australia Ltd. is an Australian private company located in St. Leonards that represents manufacturers and distributors of consumer healthcare products. Deon Schoombie is the current CEO of the firm.
10
| Private Company | Miscellaneous Commercial Services | 10 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Phillip Lynch via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
| RESP HEAL | Packaged Software | Director/Board Member | |
| Karolinska Institutet | College/University | Undergraduate Degree | |
American Chemical Society
 American Chemical Society Miscellaneous Commercial ServicesCommercial Services American Chemical Society engages as a scientific society which supports scientific inquiry in the field of chemistry. The company was founded in 1876 and is headquartered in Washington, DC. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| PHARMING GROUP N.V. | Pharmaceuticals: Major | Sales & Marketing | |
| FIRST LITHIUM LIMITED | Other Metals/Minerals | Director/Board Member | |
Monash University
 Monash University Other Consumer ServicesConsumer Services Monash University operates as a public research university. It specializes in higher education, global engagement, postgraduate courses, undergraduate study, and PhD research. The company was founded on March 1961 and is headquartered in Clayton, Australia. | College/University | Graduate Degree Undergraduate Degree | |
| TRIVARX LIMITED | Packaged Software | Director/Board Member | |
Cerylid Biosciences Ltd.
 Cerylid Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Cerylid Biosciences Ltd. is an Australian pharmaceutical company that manufactures pharmaceutical products. The private company is based in Richmond, Australia. | Pharmaceuticals: Major | Chief Executive Officer Corporate Secretary | |
| The University of New South Wales | College/University | Undergraduate Degree | |
| Macquarie University | College/University | Graduate Degree | |
| The University of Queensland | College/University | Doctorate Degree | |
| The University of Sydney | College/University | Doctorate Degree Graduate Degree | |
| London School of Economics & Political Science | College/University | Graduate Degree | |
The University of Texas M.D. Anderson Cancer Center
 The University of Texas M.D. Anderson Cancer Center Other Consumer ServicesConsumer Services The University of Texas M.D. Anderson Cancer Center provides cancer patient care, research, and prevention for cancer. The firm also provides education for undergraduate and graduate students, trainees, professionals, employees and the publics. The company was founded in 1941 and is headquartered in Houston, TX. | Other Consumer Services | Corporate Officer/Principal | |
| University of Wollongong | College/University | Undergraduate Degree | |
| The University of Western Australia | College/University | Undergraduate Degree Undergraduate Degree | |
| The Royal College of Physicians | College/University | Corporate Officer/Principal | |
Australian Institute of Co. Directors
 Australian Institute of Co. Directors Miscellaneous Commercial ServicesCommercial Services Australian Institute of Co. Directors is a non-profit organization that provides leadership on director issues. It offers governance education, director development, and advocacy. The organization was founded in January 1, 1990 and is headquartered in Sydney, Australia. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| IMPEDIMED LIMITED | Medical Specialties | Director/Board Member | |
| DIMERIX LIMITED | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
Merk Sharp & Dohme (Holdings) Pty Ltd.
 Merk Sharp & Dohme (Holdings) Pty Ltd. Pharmaceuticals: MajorHealth Technology Merk Sharp & Dohme (Holdings) Pty Ltd. develops, manufactures and markets drug therapies. The company was founded in 1958 and is headquartered in Macquarie Park, Australia. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| EMPREENDIMENTOS PAGUE MENOS S.A. | Drugstore Chains | Chief Executive Officer | |
| Royal Australian Chemical Institute, Inc. | Corporate Officer/Principal | ||
Torreya Partners LLC
 Torreya Partners LLC Investment ManagersFinance Torreya Partners LLC engages in provision of financial advisory services. The company was founded by Tim Opler and Mark Simon in 2007 and is headquartered in New York, NY. | Investment Managers | Corporate Officer/Principal | |
| ADALTA LIMITED | Biotechnology | Director/Board Member | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin | |
| Sanofi-Aventis Healthcare Pty Ltd. | Corporate Officer/Principal | ||
Doctor Care Anywhere Ltd.
 Doctor Care Anywhere Ltd. Medical/Nursing ServicesHealth Services Doctor Care Anywhere Ltd. provides healthcare services via video and phone consultation. It offers prescriptions, referrals and fit notes, health tracking, and patient record services. The company was founded by Farzad Entikabi, Michael Stein and Bayju Thakar in 2013 and is headquartered in London, the United Kingdom. | Medical/Nursing Services | Chief Executive Officer | |
Xenothera SAS
 Xenothera SAS BiotechnologyHealth Technology Xenothera SAS is a biotechnologies company. It creates therapeutic modes in numerous domains from immunomodulation to infectious diseases. The company was founded on June 30, 2014 and is headquartered in | Biotechnology | Corporate Officer/Principal | |
EpiAxis Therapeutics Pty Ltd.
 EpiAxis Therapeutics Pty Ltd. BiotechnologyHealth Technology EpiAxis Therapeutics Pty Ltd. engages in biotechnology company. It pursuing a preclinical and clinical drug development program directed at the prevention of metastatic disease by targeting the pivotal enzyme system controlling the proliferation of cancer stem cells. The company was founded by Jeremy Chrisp and Sudha Rao and is headquartered in Canberra, Australia. | Biotechnology | Chairman | |
| NEUROSCIENTIFIC BIOPHARMACEUTICALS LIMITED | Biotechnology | Chairman | |
| SIMBLE SOLUTIONS LIMITED | Packaged Software | Director/Board Member | |
Theraly Fibrosis, Inc.
 Theraly Fibrosis, Inc. Pharmaceuticals: MajorHealth Technology Theraly Fibrosis, Inc. operates as a commercial physical research company. The company was founded by Seulki Lee and is headquartered in Germantown, MD. | Pharmaceuticals: Major | Director/Board Member | |
Hangzhou Adlai Nortye Biopharma Co. Ltd.
 Hangzhou Adlai Nortye Biopharma Co. Ltd. BiotechnologyHealth Technology Part of Adlai Nortye Ltd., Hangzhou Adlai Nortye Biopharma Co. Ltd. is a clinical-stage biopharmaceutical company based in Hangzhou, China. Adlai Nortye is developing differentiated, innovative immuno-oncology medicines with a focus on discovering and developing important new treatments for cancer. The Chinese company's mission is to improve patient lives by identifying and developing differentiated innovative medicines that help people live better and longer. The company was founded in 2004 by Yang Lu, Dong Hui Yang, and Yang Lu has been the CEO since then. | Biotechnology | Chief Tech/Sci/R&D Officer | |
HaemaLogiX Pty Ltd.
 HaemaLogiX Pty Ltd. BiotechnologyHealth Technology HaemaLogiX Pty Ltd. is a biotech company located in Sydney, Australia. The Australian company has a wide range and depth of experience in antibody research, nonclinical & clinical development, manufacturing, and commercialization. The scientific advisory board members are internationally recognized experts in monoclonal antibody therapies and hematology. The company's current research and clinical trial partners are leaders in multiple myeloma and AL amyloidosis therapy. Founded in 2014, the company is researching immune-based treatments such as monoclonal antibodies, CAR T cell therapies, and bispecific antibodies to target unique antigens on malignant cells and improve the quality of life of patients suffering from blood cancers like multiple myeloma and other life-threatening diseases like AL amyloidosis. Bryce D. Carmine has been the CEO of the company since 2015. | Biotechnology | Chairman Chief Executive Officer | |
| University of New South Wales Built Environment | College/University | Doctorate Degree | |
| School of Biotechnology & Biomolecular Sciences | College/University | Doctorate Degree | |
| Twenty 1 Corporate Pty Ltd. | Corporate Officer/Principal | ||
| TRYPTAMINE THERAPEUTICS LIMITED | Pharmaceuticals: Major | Founder Director/Board Member | |
| Biosynergy Partners LLC | Corporate Officer/Principal | ||
| PKF Sydney Pty Ltd. | Corporate Officer/Principal | ||
| Ceramedix Holdings LLC | Director/Board Member | ||
| Nucleics Ltd. | Chief Executive Officer | ||
| Fia Business School | College/University | Masters Business Admin | |
Map of Medicine Ltd.
 Map of Medicine Ltd. Commercial Printing/FormsCommercial Services Map of Medicine Ltd. publishes a web-based database of medical content. The firm offers comprehensive, evidence-based local guidance and clinical decision support at the point of care. The company was founded in 2000 and is headquartered in London, the United Kingdom. | Commercial Printing/Forms | Chief Executive Officer | |
Chartered Accountants Australia & New Zealand
 Chartered Accountants Australia & New Zealand Miscellaneous Commercial ServicesCommercial Services Chartered Accountants Australia & New Zealand is an association for chartered accountants that provides accounting services. The non-profit company is based in Auckland, New Zealand. | Miscellaneous Commercial Services | Corporate Officer/Principal |
Statistics
International
| Australia | 28 |
| United States | 10 |
| United Kingdom | 6 |
| Brazil | 3 |
| Sweden | 2 |
Sectoral
| Health Technology | 17 |
| Consumer Services | 16 |
| Commercial Services | 5 |
| Technology Services | 4 |
| Non-Energy Minerals | 2 |
Operational
| Director/Board Member | 59 |
| Corporate Secretary | 30 |
| Corporate Officer/Principal | 26 |
| Chief Executive Officer | 19 |
| Founder | 17 |
Most connected contacts
| Insiders | |
|---|---|
| Peter Webse | 31 |
| Garner William | 22 |
| Mary Harney | 16 |
| John Cullity | 13 |
| Christopher Ntoumenopoulos | 11 |
| Peter Smith | 10 |
| Daniel Sharp | 7 |
| Damian Clarke-Bruce | 6 |
| Daniel Tillett | 5 |
| Michael Kelso | 5 |
| David Fuller | 4 |
| Marinella Messina | 4 |
| Christina Manfre | 4 |
| Jonas Marques Neto | 3 |
| Michelle Rashford | 3 |
- Stock Market
- Insiders
- Phillip Lynch
- Company connections